Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 231 clinical trials
Featured trial
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma

Gene transfer is a new cancer therapy takes white blood cells from a person and grows them in a lab. The cells are changed with a virus to attack tumor cells, then returned to the person. Researchers want to see if this therapy fights kidney cancer cells. Metastatic renal cell …

renal cell cancer
carcinoma
metastatic cancer
clear cell carcinoma
clear cell renal cell carcinoma
  • 208 views
  • 22 Dec, 2020
  • 1 location
Featured trial
Pneumonia Vaccine

Are you due for a pneumonia vaccine and a COVID Booster? The team at AMR Kansas City are now enrolling healthy volunteers in an investigational pneumonia vaccine clinical research study.&nbsp

pneumonia
Accepts healthy volunteers
booster
  • 12 views
  • 23 Dec, 2021
  • 1 location
Featured trial
Pilot: Fear Extinction and Mechanisms of Change in Obsessive Compulsive Disorder

Pilot: Fear Extinction and Mechanisms of Change in Obsessive Compulsive Disorder

  • 776 views
  • 23 Nov, 2020
  • 1 location
Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

The purpose of this research is to see if a dose of the Janssen Ad26.CoV2.S vaccine effects the immune protection in individuals who have had a kidney transplant and two or three doses of mRNA vaccine (Pfizer and/or Moderna vaccines).

  • 0 views
  • 24 Apr, 2022
  • 3 locations
Phase 3 Study to Evaluate a Single Booster of the NVX-CoV2373 COVID19 Vaccine in Adults

This is an observer-blinded Phase 3 study to evaluate the safety and immunogenicity of a single booster dose of the Novavax severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2

Accepts healthy volunteers
  • 0 views
  • 10 Apr, 2022
Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine

This study aims to address evidence gaps regarding the safety, reactogenicity and immune responses of a heterologous boost of a single dose of Ad26.COV2.S (half or full dose) at pre-specified time intervals in recipients who are documented to have received either 1-dose or 2-doses (primary series completion) of inactivated COVID-19 …

Accepts healthy volunteers
  • 0 views
  • 15 Mar, 2022
A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19

The purpose of this study is to assess the safety, tolerability, and immunogenicity of booster dose of vaccine in participants who are generally healthy or with stable pre-existing health

Accepts healthy volunteers
  • 0 views
  • 27 Apr, 2022
  • 4 locations
A Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19

This is a 2-part study to evaluate the immunogenicity, safety, and reactogenicity of mRNA-1273.529 and mRNA-1273.214 administered as a booster dose.

Accepts healthy volunteers
  • 0 views
  • 30 Apr, 2022
  • 5 locations
A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age

The primary goal for this study is to evaluate up to 3 dose levels of mRNA-1273 vaccine given to healthy children in 2 doses (in Parts 1 and 2) and 3 doses (in Part 3), and an optional booster

Accepts healthy volunteers
  • 295 views
  • 13 May, 2022
  • 66 locations
  • 0 views
  • 22 Apr, 2022
  • 1 location